These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28980909)

  • 1. Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?
    Martini G; Campus S; Raffeiner B; Boscarol G; Meneghel A; Zulian F
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):211-213. PubMed ID: 28980909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
    Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Pansclerotic Morphea Treated With Tocilizumab.
    Zhang A; Nocton J; Chiu Y
    JAMA Dermatol; 2019 Mar; 155(3):388-389. PubMed ID: 30649148
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.
    Ventéjou S; Schwieger-Briel A; Nicolai R; Christen-Zaech S; Schnider C; Hofer M; Bogiatzi S; Hohl D; De Benedetti F; Morren MA
    Front Immunol; 2021; 12():656407. PubMed ID: 33767715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 blockers in systemic onset juvenile idiopathic arthritis.
    Barone P; Pignataro R; Garozzo MT; Leonardi S
    Immunotherapy; 2016; 8(1):79-87. PubMed ID: 26642378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea.
    Rose RF; Goodfield MJ
    Clin Exp Dermatol; 2005 May; 30(3):226-8. PubMed ID: 15807674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.
    Lythgoe H; Baildam E; Beresford MW; Cleary G; McCann LJ; Pain CE
    Rheumatology (Oxford); 2018 Feb; 57(2):398-401. PubMed ID: 29077971
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.
    Vaglio A; Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Macchioni P; Pulsatelli L; Nicastro M; Becchi G; Corradi D; Versari A; Boiardi L; Salvarani C
    Arthritis Rheum; 2013 Sep; 65(9):2469-75. PubMed ID: 23740665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
    Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
    Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUVA therapy for disabling pansclerotic morphoea of children.
    Todd DJ; Askari A; Ektaish E
    Br J Dermatol; 1998 Jan; 138(1):201-2. PubMed ID: 9536257
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
    Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
    Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis.
    Mitchell E; Jones G
    Expert Rev Clin Immunol; 2016; 12(2):103-14. PubMed ID: 26629984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
    Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With Tocilizumab.
    Osminina M; Geppe N; Afonina E
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):356-358. PubMed ID: 29929808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.